GBIG

131 Oyster Point Blvd

Building

Building 131 Oyster Point Blvd

South San Francisco, CA, USA

Ambys Medicines, Alector Therapeutics, Harpoon Therapeutics

Favorite + Add to a Collection
+ Add Me

Details

Icon-transparency Transparency

This building has a 5 year timeline with 6 green activities including a LEED Silver certification.

Timeline

Activity
Alector Therapeutics
awarded on 02/21/2022
Silver
LEED v4 ID+C CI
Activity
Harpoon Therapeutics
awarded on 01/05/2022
Silver
LEED v4 ID+C CI
Activity
Ambys Medicines
awarded on 06/21/2021
Silver
LEED v4 ID+C CI
Activity
Harpoon Therapeutics
registered on 01/25/2019
Registered
LEED v4 ID+C CI
Activity
Alector Therapeutics
registered on 11/06/2018
Registered
LEED v4 ID+C CI
Activity
Ambys Medicines
registered on 10/17/2018
Registered
LEED v4 ID+C CI

Walk Score®: 47/100

Resources

Building Details

Owner Type(s) Corporate: Privately Held, Corporate: Publicly Traded
Space Type(s) Laboratory
CBSA San Francisco-Oakland-Fremont, CA
USGBC Chapter Northern California Chapter
EPA Region Pacific Southwest
NHCS Urban Rural Classification Large fringe metro
Report a Data Problem

This website collects and uses cookies to ensure you get the best user experience.

Please click on "Accept and Close" button to affirm your consent and continue to use our website. For more information, please view our Cookies Statement.